Medical Devices


Using state-of-the-art equipment, you can rely on our orthopedic testing methods to provide comprehensive expertise to the development and delivery of your devices.

Your choice for quality preclinical development

Benefit from our streamlined approach & expertise in orthopedic device research 

Testing orthopedic devices and implants is an important activity impacting the creation of each specific device. One in four people in the US suffer from musculoskeletal impairment, and our team of experts have comprehensive training to use and research a variety of devices that are needed by these patients.

Noble Life Sciences provides support and expertise in the following areas:

  • Joint Models
  • Osteoarthritis
  • Arthroplasty (hip, knee) and other types of articular cartilage repair
  • Anterior cruciate ligament (ACL) repair/meniscectomy
  • Artificial meniscus
  • Reconstruction/fixation of other ligaments and tendons
  • Artificial ligaments and tendons
  • Bone Defect Models
  • Osteotomy of femur, tibia and radius
  • Critical size defect models in the calvarium, tibia, fibula, femur, radius and ulna
  • Spinal Fusion Models
  • PLIF
Let Noble Life Sciences’ unparalleled expertise and state-of-the-art facilities be your trusted partner for all of your preclinical biodistribution and shedding studies. We have worked with xx organizations to bring xx new therapies to market.

How Our Team Can Help

With decades of GLP experience, our scientists can support all aspects of the GLP process, from design to regulatory support of your IND, IDE, or PMA FDA submission.

Ali Mohammadabadi, Ph.D.

Ali Mohammadabadi, Ph.D.

Study Director

Ivan Tatarov, D.V.M.

Ivan Tatarov, D.V.M.

Clinical Veterinarian

Let’s talk about your orthopedic devices practices

Resources & White Papers


Mouse Peritonitis/Sepsis Model of MRSA Infection

Mouse Peritonitis/Sepsis Model of MRSA Infection

Noble Life Sciences, in collaboration with ImQuest Biosciences, has optimized the peritonitis/sepsis mouse model to screen for new antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). The model’s popularity derives from its ease of use with small and expensive animals, short-duration experiments with reproducible infections, and simple end-points.

read more